Filing Details

Accession Number:
0001179110-13-015777
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-28 17:16:08
Reporting Period:
2012-04-06
Filing Date:
2013-10-28
Accepted Time:
2013-10-28 17:16:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
203077 St Jude Medical Inc STJ Electromedical & Electrotherapeutic Apparatus (3845) 411276891
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1533175 Joel Becker One St. Jude Medical Drive
St. Paul MN 55117
President - Usd No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-04-06 249 $0.00 1,111 No 4 M Direct
Common Stock Disposition 2012-04-06 82 $40.97 1,029 No 4 F Direct
Common Stock Acquisiton 2012-10-31 875 $0.00 1,904 No 4 M Direct
Common Stock Disposition 2012-10-31 233 $38.26 1,671 No 4 F Direct
Common Stock Disposition 2013-10-24 1,135 $56.50 3,715 No 4 S Direct
Common Stock Acquisiton 2013-10-24 5,332 $41.65 9,047 No 4 M Direct
Common Stock Disposition 2013-10-24 5,332 $56.48 3,715 No 4 S Direct
Common Stock Disposition 2013-10-24 3,146 $56.47 569 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2012-04-06 249 $0.00 996 $0.00
Common Stock Restricted Stock Units Disposition 2012-10-31 875 $0.00 3,500 $0.00
Common Stock Stock Option (Right to Buy) Disposition 2013-10-24 5,332 $0.00 10,664 $41.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
747 2012-04-06 No 4 M Direct
2,625 2012-10-31 No 4 M Direct
5,332 2011-12-14 2018-12-14 No 4 M Direct
Footnotes
  1. Fully vested at the time of filing.
  2. The price in Column 4 is a weighted average. The prices actually received ranged from $56.47 to $56.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. The price in Column 4 is a weighted average. The prices actually received ranged from $56.47 to $56.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  4. The total number of securities beneficially owned has been adjusted to correctly reflect that 573 shares (rather than 708 shares) were withheld to pay taxes in connection with a transaction described on Mr. Becker's Form 4 filed on Dec 14, 2012.
  5. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
  6. The restricted stock units will vest 25% on each of the first four anniversary dates of the date of the grant beginning the date shown.
  7. 249 shares of restricted stock vested on April 6, 2012. 82 shares were used to pay taxes and 167 were released.
  8. 875 shares of restricted stock vested on April 6, 2012. 233 shares were used to pay taxes and 642 were released.